Delivery Order SPE2DB20D3304-SPE2DB25FW4T2

Award Date 12/5/24
Potential Completion Date 12/6/24
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB25FW4T2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Eliquis 5 mg tablets, a cardiovascular medication, with a ceiling value of $6,133.37 and a period of performance through December 6, 2024. The contract was awarded on December 5, 2024 and has a firm fixed price pricing type.

AmerisourceBergen is a for-profit organization that has been registered in the System for Award Management (SAM.gov) since 2002. The company specializes in distributing a wide range of pharmaceutical products, medical supplies, and equipment to federal agencies, with a significant focus on supporting military and veterans' healthcare programs through its extensive contracts with the DLA. This award is likely part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of critical medical commodities.

The contract does not have a set-aside designation, indicating open competition. No subcontractors are mentioned in the provided information.

Generated 3/6/25, 10:05 AM